COMPOUND INHIBITING AND INDUCING DEGRADATION OF EGFR AND ALK

A new compound of general formula (X) inhibiting and inducing degradation of an EGFR and ALK, and a pharmaceutical composition containing said compound. The compound and the pharmaceutical composition can be used for treating diseases related to the EGFR and the ALK kinase, such as cancer. The prese...

Full description

Saved in:
Bibliographic Details
Main Authors Liu, Xuelian, Wang, Yeming, Jiang, Yuanyuan, Liang, Huining, Fan, Futian, Wang, Xiaoqian, Feng, Zewang, Zhang, Yanhao, Zhao, Yanping, Wang, Hongjun, Xie, Yong, Liu, Kai
Format Patent
LanguageEnglish
Published 29.09.2022
Subjects
ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM
CHEMISTRY
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:A new compound of general formula (X) inhibiting and inducing degradation of an EGFR and ALK, and a pharmaceutical composition containing said compound. The compound and the pharmaceutical composition can be used for treating diseases related to the EGFR and the ALK kinase, such as cancer. The present invention further provides the preparation and use of the compound.
Bibliography:Application Number: US202017637690